Affordable Access

Access to the full text

Interactions of neuroimmune signaling and glutamate plasticity in addiction

Authors
  • Gipson, Cassandra D.1
  • Rawls, Scott2
  • Scofield, Michael D.3, 3
  • Siemsen, Benjamin M.3
  • Bondy, Emma O.1
  • Maher, Erin E.1
  • 1 University of Kentucky, 741 S. Limestone, BBSRB, Room 363, Lexington, KY, 40536-0509, USA , Lexington (United States)
  • 2 Temple University, Philadelphia, USA , Philadelphia (United States)
  • 3 Medical University of South Carolina, Charleston, USA , Charleston (United States)
Type
Published Article
Journal
Journal of Neuroinflammation
Publisher
Springer (Biomed Central Ltd.)
Publication Date
Feb 21, 2021
Volume
18
Issue
1
Identifiers
DOI: 10.1186/s12974-021-02072-8
Source
Springer Nature
Keywords
License
Green

Abstract

Chronic use of drugs of abuse affects neuroimmune signaling; however, there are still many open questions regarding the interactions between neuroimmune mechanisms and substance use disorders (SUDs). Further, chronic use of drugs of abuse can induce glutamatergic changes in the brain, but the relationship between the glutamate system and neuroimmune signaling in addiction is not well understood. Therefore, the purpose of this review is to bring into focus the role of neuroimmune signaling and its interactions with the glutamate system following chronic drug use, and how this may guide pharmacotherapeutic treatment strategies for SUDs. In this review, we first describe neuroimmune mechanisms that may be linked to aberrant glutamate signaling in addiction. We focus specifically on the nuclear factor-kappa B (NF-κB) pathway, a potentially important neuroimmune mechanism that may be a key player in driving drug-seeking behavior. We highlight the importance of astroglial-microglial crosstalk, and how this interacts with known glutamatergic dysregulations in addiction. Then, we describe the importance of studying non-neuronal cells with unprecedented precision because understanding structure-function relationships in these cells is critical in understanding their role in addiction neurobiology. Here we propose a working model of neuroimmune-glutamate interactions that underlie drug use motivation, which we argue may aid strategies for small molecule drug development to treat substance use disorders. Together, the synthesis of this review shows that interactions between glutamate and neuroimmune signaling may play an important and understudied role in addiction processes and may be critical in developing more efficacious pharmacotherapies to treat SUDs.

Report this publication

Statistics

Seen <100 times